Research and Reviews
Current Topics in OCD & Spectrum Disorders
To increase awareness of and to highlight recent discoveries, scientific findings and the current understanding of OCD, we are providing regular reviews of research articles. We will regularly chose a recent or important older article and introduce its main findings and lessons learned.
Please note that these reviews are merely a popularization of the articles; thus, the intricacies of the results and the authors' explanations may not be provided in full and/or the messages of the articles may be generalized so that lay readers can understand the main point of the article. In addition, these reviews do not constitute a recommendation for/against or judgement of any of the treatments or opinions discussed.
Featured Review
Articles for Researchers and Clinicians
Announcements & Upcoming Events
LACPA 2012 Brown Bag Lecture
January 9, 2012
LACPA Office
Dr. Gorbis will be lecturing on the "Comorbidity of OCD and Eating Disorders and its Implication to Treatment" to members of the LA County Psychological Association. She will be addressing the issue of comorbidity of OCD and eating disorders and the implications of each disorders in terms of etiology as well as treatment.
True Life on MTV: I Hate My Face!
Dr. Eda Gorbis was featured in MTV's show, "TrueLife", a powerful, award-winning series that uniquely reflects the experiences and cultures of this generation.This episode documents the unusual—and often remarkable circumstances of real individuals with Body Dysmorphic Disorder.
Learn more about Body Dysmorphic Disorder on our blog.
Medical research study of an investigational medicine for patients with OCD who have not responded to treatment with SSRIs
To pre-qualify for this study, patients must be at least 18 yrs. old, have a documented diagnosis of OCD as defined by the DSM-IV-TR, have been taking one of the following SSRIs for at least six weeks prior to screening and at the minimum daily dosage listed: fuvoxamine (Luvox®) 200 mg, fluoxetine (Prozac®) 40 mg, paroxetine (Paxil®) 40 mg, sertraline (Zoloft®) 100 mg.
The study is expected to last about 20 weeks. Each patient will receive study medication and study-related medical evaluations at no cost. Reimbursement for travel may also be provided.
Please contact us for additional eligibility requirements.
Dr. Gorbis' interview on Body Dysmorphic Disorder now available to watch at psychotherapy.net!
Dr. Gorbis talks about Body Dysmorphic order, its successful treatment methods, and resources for therapists. Watch it now at http://www.psychotherapy.net/interview/eda-gorbis-body-dysmorphic.